Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Butcher

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Neurotrauma|October 27, 2011
Does the extended Glasgow Outcome Scale add value to the conventional Glasgow Outcome Scale?James Weir, Ewout W Steyerberg, Isabella Butcher, et al.
The Lancet. Neurology|October 22, 2013
Advancing care for traumatic brain injury: findings from the IMPACT studies and perspectives on future researchAndrew I R Maas, Gordon D Murray, Bob Roozenbeek, et al.
Journal of Neurotrauma|June 27, 2008
Effects of Glasgow Outcome Scale misclassification on traumatic brain injury clinical trialsJuan Lu, Gordon D Murray, Ewout W Steyerberg, et al.
Neurosurgery|February 12, 2011
Large between-center differences in outcome after moderate and severe traumatic brain injury in the international mission on prognosis and clinical trial design in traumatic brain injury (IMPACT) studyHester F Lingsma, Bob Roozenbeek, Bayoue Li, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 5, 2010
IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injuryAndrew I R Maas, Ewout W Steyerberg, Anthony Marmarou, et al.
Critical Care Medicine|November 4, 2009
Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?Bob Roozenbeek, Andrew I R Maas, Hester F Lingsma, et al.
Journal of Neurotrauma|March 23, 2007
Prognostic value of demographic characteristics in traumatic brain injury: results from the IMPACT studyNino A Mushkudiani, Doortje C Engel, Ewout W Steyerberg, et al.
Journal of Neurotrauma|March 23, 2007
Prognostic value of admission laboratory parameters in traumatic brain injury: results from the IMPACT studyJackelien G M Van Beek, Nino A Mushkudiani, Ewout W Steyerberg, et al.
Journal of Neurotrauma|March 23, 2007
Prognostic value of secondary insults in traumatic brain injury: results from the IMPACT studyGillian S McHugh, Doortje C Engel, Isabella Butcher, et al.
Critical Care Medicine|April 19, 2012
Prediction of outcome after moderate and severe traumatic brain injury: external validation of the International Mission on Prognosis and Analysis of Clinical Trials (IMPACT) and Corticoid Randomisation After Significant Head injury (CRASH) prognostic modelsBob Roozenbeek, Hester F Lingsma, Fiona E Lecky, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Neurotrauma|October 27, 2011
Does the extended Glasgow Outcome Scale add value to the conventional Glasgow Outcome Scale?James Weir, Ewout W Steyerberg, Isabella Butcher, et al.
The Lancet. Neurology|October 22, 2013
Advancing care for traumatic brain injury: findings from the IMPACT studies and perspectives on future researchAndrew I R Maas, Gordon D Murray, Bob Roozenbeek, et al.
Journal of Neurotrauma|June 27, 2008
Effects of Glasgow Outcome Scale misclassification on traumatic brain injury clinical trialsJuan Lu, Gordon D Murray, Ewout W Steyerberg, et al.
Neurosurgery|February 12, 2011
Large between-center differences in outcome after moderate and severe traumatic brain injury in the international mission on prognosis and clinical trial design in traumatic brain injury (IMPACT) studyHester F Lingsma, Bob Roozenbeek, Bayoue Li, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 5, 2010
IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injuryAndrew I R Maas, Ewout W Steyerberg, Anthony Marmarou, et al.
Critical Care Medicine|November 4, 2009
Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?Bob Roozenbeek, Andrew I R Maas, Hester F Lingsma, et al.
Journal of Neurotrauma|March 23, 2007
Prognostic value of demographic characteristics in traumatic brain injury: results from the IMPACT studyNino A Mushkudiani, Doortje C Engel, Ewout W Steyerberg, et al.
Journal of Neurotrauma|March 23, 2007
Prognostic value of admission laboratory parameters in traumatic brain injury: results from the IMPACT studyJackelien G M Van Beek, Nino A Mushkudiani, Ewout W Steyerberg, et al.
Journal of Neurotrauma|March 23, 2007
Prognostic value of secondary insults in traumatic brain injury: results from the IMPACT studyGillian S McHugh, Doortje C Engel, Isabella Butcher, et al.
Critical Care Medicine|April 19, 2012
Prediction of outcome after moderate and severe traumatic brain injury: external validation of the International Mission on Prognosis and Analysis of Clinical Trials (IMPACT) and Corticoid Randomisation After Significant Head injury (CRASH) prognostic modelsBob Roozenbeek, Hester F Lingsma, Fiona E Lecky, et al.
Pageof 4